Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Round-up

October 16, 2006 | A version of this story appeared in Volume 84, Issue 42

Sigma-Aldrich has acquired Advanced Separation Technologies (Astec), a New Jersey-based chiral chromatography business. Astec, which develops and manufactures chiral chromatography media and columns, will operate as part of Sigma-Aldrich's research specialties business unit.

Crucell, a Dutch biotechnology firm, says it has been awarded a $16.2 million contract by the National Institute of Allergy & Infectious Diseases, part of the U.S. National Institutes of Health, to develop a vaccine against HIV. Crucell's program focuses on the use of live viral vectors for the design and development of vaccines.

Lubrizol has opened an industrial lubricant additives laboratory in Shanghai. The facility is capable of formulation and development, as well as physical and performance testing of metalworking, grease, hydraulics, and industrial gear oils.

Lonza says that its previously announced spin-off of polymer intermediates received a boost when the Milan Stock Exchange cleared the listing of the new company, named Polynt SpA. The offering still has to be approved by Italian stock market regulators. After that, Lonza can set the timing for an initial public offering of the unit.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.